and destabilization, the nature of the actual trigger for (peri)vascular mast cell activation during atherosclerosis is still unresolved. Objective: In this study, we confirm that perivascular mast cell content correlates with the number of nerve fibers in the adventitia of human coronary atherosclerotic plaque specimen. Because peripheral C-type nerve fibers secrete, among others, substance P, a potent mast cell activator, we set out to study effects of adventitial administration of this neuropeptide on mast cell dependent destabilization of carotid artery plaques in apolipoprotein E-deficient (apoE ؊/؊ ) mice. Methods and Results: Substance P treatment significantly enhanced the number and activation status of adventitial mast cells compared to controls and promoted intraplaque hemorrhages. These phenomena could be prevented by coadministration of the neurokinin-1 receptor antagonist spantide I and did not occur in mast cell deficient apoE ؊/؊ mice, establishing the critical involvement of mast cells in substance P-elicited plaque destabilization. Conclusions: Our data suggest that neurotransmitters such as substance P are capable of promoting mast cell dependent plaque destabilization and provide a new, direct link between neural factors and vascular inflammation. (Circ Res. 2010;106:89-92.)
A cute coronary syndromes are generally caused by atherosclerotic plaque rupture. 1, 2 Mast cells, major players in allergy and asthma, 3 were found to be abundantly present in the intima and adventitia of unstable human atherosclerotic lesions 4, 5 and recently, we and others have conclusively demonstrated that (peri)vascular mast cells contribute to atherosclerotic plaque progression and destabilization in mice. 6, 7 However, the nature of potential mast cell triggers in atherosclerosis is still unresolved.
Adventitial mast cells in human lesions have been reported to colocalize with nerve fibers, 8 fueling the intriguing option of neuronal regulation of mast cell activation. Neuropeptides such as substance P are predominantly released by peripheral C-type sensory neurons 9 and have been demonstrated to be involved in psychological stress-induced disorders 10 and in stress-related cardiovas-cular events and inflammation. 11 Mast cell activation by neuropeptides proceeds through dedicated receptors, such as neurokinin-1 receptor (NK1R) or by direct activation of G proteins. 12, 13 Because tryptase-positive mast cells were seen to colocalize with substance P-positive nerve fibers in skin 14 and in adventitial tissue, 8 this potent mast cell activator may be a likely candidate to mediate perivascular mast cell recruitment and activation in response to stress. In this study, we addressed the role of substance P in mast cell dependent plaque progression and destabilization. CD117 antibody (Dako), whereas nerves were visualized with a neurofilament (NF) antibody (Biogenex Laboratories Inc).
Male apolipoprotein E-deficient (apoE Ϫ/Ϫ ) mice were fed a Western type diet, containing 0.25% cholesterol and 15% cacao butter. After 6 weeks of collar induced atherosclerotic lesion development, the mice were treated perivascularly by applying pluronic F-127 gel (Sigma) or gel containing substance P (0.5 g/animal, Sigma) at the lesion site. Three days later, the animals were anesthetized and perfusion-fixation was performed, after which, the carotid artery lesions were analyzed.
Results and Discussion

Human Coronary Artery Analysis
In analogy to previous studies by Kovanen and colleagues, 8 analysis of human coronary artery specimens revealed that with lesion progression, the number of adventitial mast cells enhances from 19Ϯ5 in class 1 to 2 lesions to 83Ϯ11 adventitial mast cells in advanced class 5 to 6 lesions (Pϭ0.0001; Figure 1A and 1B). In type 1 to 2 lesions, we did not detect any intraplaque hemorrhages (0/8), whereas in type 5 to 6 lesions in 9 of 16 plaques contained extravasated intimal erythrocytes and these plaques can be classified as intraplaque hemorrhaged (Pϭ0.01). The number of NF-positive nerve fibers in the adventitia of human coronary plaques tended to be increased during atherosclerotic lesion progression from 15Ϯ1 in class 1 to 2 to 23Ϯ2 fibers in class 5 to 6 (Pϭ0.1; Figure 1C and 1D). The number of adventitial mast cells strongly correlated with progression stage (PϽ0.0001, rϭ0.73), whereas that of adventitial NF-positive nerve fibers also correlated with plaque progression (PϽ0.05, rϭ0.42). Furthermore, adventitial mast cell number correlated with the number of adventitial nerve fibers (PϽ0.05, rϭ0.42). Thus, these data may point to a relationship between adventitial mast cell content and the presence of nerve fibers in the perivascular tissue of advanced atherosclerotic plaques. The findings that mast cells colocalize with substance P-positive nerve fibers in skin 14 and adventitia 8 and can be activated by substance P 12, 13 suggest that this neuropeptide may contribute to mast cell activation in perivascular tissue in advanced atherosclerosis as well.
MC Activation In Vitro
Activation of freshly isolated peritoneal mast cells (PMCs) or MC/9 mast cells with 0.5 g/mL compound 48/80 (reference activator) or with 50 mol/L substance P resulted in different releasate composition as demonstrated in Figure 2 and the expanded Results section in the Online Data Supplement. These data demonstrate not only that secretion patterns differ considerably depending on the route of mast cell activation, but also that substance P is able to activate murine mast cells in vitro, mainly resulting in mast cell protease release.
Substance P Induced Mast Cell Recruitment and Plaque Destabilization via the NK1R
To investigate effects of neuropeptide substance P on the recruitment and activation of adventitial mast cells, we placed semiconstrictive collars at the carotid arteries of Western- type diet fed apoE Ϫ/Ϫ mice. After 6 weeks, when advanced plaques had formed, we topically applied a pluronic gel containing substance P (0.5 g/mouse, 10 L per artery) or control gel at the lesion site. Three days later, the atherosclerotic plaques were analyzed. As expected, plaque size did not differ between the control or substance P treatment groups. 6 An increased presence of adventitial mast cells was detected in the substance P-treated group compared to controls (4.9Ϯ0.8 mast cells/mm 2 tissue and 2.2Ϯ0.5 mast cells/mm 2 tissue, PϽ0.05; Figure 3A) . Moreover, the percentage of activated mast cells was increased (substance P: 56Ϯ9%, control: 29Ϯ9%; PϽ0.05; Figure 3B ). To address the in- Figure 2 . Substance P induced mast cell activation in vitro. Incubation of mast cells with substance P results in mast cell activation as shown by toluidine staining. Analysis of mast cell releasate showed that substance P is a potent inducer of tryptic and chymotryptic activity in the releasate from PMCs, whereas tryptic activity could also be detected in the releasate of MC/9 mast cells. Compound 48/80 resulted in higher ␤-hexosaminidase activity in the PMC releasate than substance P. IgE stimulation was used as positive reference mast cell activator. n.d. indicates not detectable. .01 compared to substance P without spantide I) (A), whereas tending to reduce substance P -induced mast cell activation (B). C, Inhibition of NK1R by spantide I also resulted in a borderline significant inhibition of the substance P-induced intraplaque hemorrhage (substance P: PϽ0.05 compared to controls; spantide I plus substance P: Pϭ0.057 compared to substance P without spantide I). In contrast to apoE Ϫ/Ϫ mice, substance P challenge in mast cell-deficient apoE Ϫ/Ϫ mice did not enhance the incidence of intraplaque hemorrhage (substance P challenge in apoE Ϫ/Ϫ Kit(W -sh /W -sh ): PϽ0.05 compared to substance P in apoE Ϫ/Ϫ mice). Typical sections of hematoxylin/eosinstained plaques are shown to demonstrate plaque morphometry (ϫ100 magnification) and presence of intraplaque erythrocytes as indicated by arrows in the substance P-challenged plaque (ϫ400 magnification, lower left micrograph; ϫ1000 magnification, middle). volvement of NK1R in this effect, the main receptor for substance P, we coapplied the NK1R antagonist spantide I. 15 Perivascular administration of spantide I alone did not affect mast cell numbers in perivascular tissue compared to controls (2.6Ϯ0.6 mast cells/mm 2 tissue, Pϭ0.59 compared to controls). However, spantide I strongly inhibited substance P -induced mast cell recruitment (substance P plus spantide I: 2.6Ϯ0.4 mast cells/mm 2 tissue; PϽ0.01 compared to substance P; Figure 3A ). Of note, spantide I also partly reversed substance P associated mast cell activation from 56Ϯ9% to 41Ϯ6%, although spantide I itself did not affect mast cell activation status (32Ϯ7% versus 29Ϯ9% in untreated controls; Figure 3B) .
Non-standard Abbreviations and Acronyms
Number of mast cells/mm
Interestingly, the incidence of intraplaque hemorrhage (defined as "masses of red blood cells free in the plaque matrix or filling the necrotic core"), 16 a widely appreciated feature of plaque destabilization, 17 was significantly increased only in the substance P-treated animals compared to control mice (5/12 or 42% in the substance P group versus 0/15 in control mice; PϽ0.05; Figure 3C ; Online Figure I , A). Most hemorrhages also stained positive for iron (Online Figure I, B ; Discussion). Because our in vitro mast cell activation studies demonstrated that substance P particularly enhanced chymotryptic and tryptic activity in the mast cell releasate, these data may point to a role for mast cell proteases in substance P-induced plaque destabilization. Inhibition of substance P by spantide I resulted in a reduction in the incidence in intraplaque hemorrhage, which was observed in only 1 of 16 plaques cochallenged with substance P and spantide I (6%; Pϭ0.057 compared to substance P; Figure 3C ).
To determine whether substance P promotes hemorrhages in a mast cell-specific manner, we induced atherosclerotic lesions in carotid arteries of apoE Ϫ/Ϫ Kit(W -sh /W -sh ) mice. Again, focal substance P challenge did not affect plaque size, and, as expected, adventitial mast cells could not be detected in these mice. Unlike in apoE Ϫ/Ϫ mice, in substance P-challenged mast cell-deficient mice, only 1 of 19 carotid artery plaques displayed intimal accumulation of erythrocytes (5% of the plaques, PϽ0.05; Figure 3C ). We did not observe any differences in perivascular CD31 ϩ microvessel density (Online Figure II and Discussion) between apoE Ϫ/Ϫ Kit(W -sh /W -sh ) mice and apoE Ϫ/Ϫ mice (data not shown). 18, 19 For a more elaborate discussion regarding this issue, see the expanded Discussion section in the Online Data Supplement. These data firmly establish that substance P induces intraplaque hemorrhages in advanced atherosclerotic plaques in a mast cell-dependent manner.
In conclusion, we here provide supportive evidence that neurotransmitters such as substance P are capable of augmenting perivascular mast cell content in experimental atherosclerosis, resulting in the increased incidence in intraplaque hemorrhage and thus increased plaque destabilization, linking stress directly to vascular inflammation and acute cardiovascular syndromes. Further elucidation of the extent and the underlying mechanisms by which neuropeptides released from nerve fibers in perivascular tissue of advanced atherosclerotic plaques contribute to plaque destabilization may lead to new therapeutic entries in the prevention of acute cardiovascular syndromes. 
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